InvestorsHub Logo
Followers 50
Posts 947
Boards Moderated 0
Alias Born 05/06/2019

Re: None

Monday, 10/19/2020 2:34:23 PM

Monday, October 19, 2020 2:34:23 PM

Post# of 62860
No products you say?

Gold River adds four additional trademarks for its future nutraceutical/CBD line. While the formulations have been completed and will remain proprietary, the names are carefully constructed to reflect usage... The trademarked names include Inflammaplex™, Energyplex™, Painplex™ and Insominoplex™ enhancing the nutraceutical line, with 15 more to be added as the product lines are perfected.
https://www.globenewswire.com/news-release/2019/06/27/1875479/0/en/XYZ-Hemp-Inc-GRPS-Gold-River-Productions-Inc-and-RushNet-Inc-RSHN-Announce-Most-Recent-Acquisitions-Alliances-Products-Grants-and-Name-Change.html

From the financials...
Additionally, for its products, it has created alternative delivery
systems utilizing a nebulizer and specially formulated, nanotized CBD, aided by a substrate (Emu oil) that mitigates cough and accentuates absorption and bioavailability. Ultimately, this technology should prove instrumental in treatment of addictive disorders, anxiety attacks, among other medical maladies.

Principal Products
The Company’s principal products have been formulated and are in various stages of production. Formulated from proven nutraceutical combinations, the therapeutic effects of these formula are augmented by our full spectrum and broad spectrum CBD. The company has also created three patient kits that will target specific disorders including obesity, drug addiction and cosmesis.

Distribution and Marketing
The Company is developing its distribution and marketing plans to include addiction centers, marijuana dispensaries, kiosks and convenient stores.

New Products - The specific products will not be named until they have been trademarked. However, they include products targeting inflammation, pain, obesity, erectile dysfunction and others. They also include the enhancement of energy and alertness. While these products have been tested successfully in the clinic, more intensive study is needed. This further testing is being planned now for study in various institutions.

https://backend.otcmarkets.com/otcapi/company/financial-report/260419/content

Trademarks
https://trademarks.justia.com/owners/grps-4144431/

Product Placement Unlimited
https://www.facebook.com/pages/category/Product-Service/Product-Placement-Unlimited-103486271374741/